Ligandal delivers. Bioactive materials are at the core of our engineering.
Ligandal's nanomedicine targets specific cells by matching proprietary ligands to cellular surface markers and receptors.
Timed release parameters may be tuned on the order of days or weeks using our bioactive peptide matrices.
Genetic payloads are optionally trafficked to the nucleus of a cell, where they are released in a compartment-specific manner.
Formulations may be reused across numerous applications to enable vastly accelerated drug discovery and screening.